Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0145-2126(01)00107-2PMID 11755471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?

  2000cited by this paper
• Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features

  1999cited by this paper
• Thrombopoietin-induced conformational change in p53 lies downstream of the p44/p42 mitogen activated protein kinase cascade in the human growth factor-dependent cell line M07e

  1999cited by this paper
• Enhanced proliferative activity of PIXY-321, the granulocyte-macrophage colony-stimulating factor and interleukin-3 fusion protein.

  1998cited by this paper
• Cytokine-mediated erythroid maturation in megakaryoblastic human cell line HU-3.

  1997cited by this paper
• Thrombopoietin Upregulates the Promoter Conformation of p53 in a Proliferation-Independent Manner Coincident With a Decreased Expression of Bax: Potential Mechanisms for Survival Enhancing Effects

  1997cited by this paper
• The human bladder carcinoma cell line 5637 constitutively secretes functional cytokines.

  1997cited by this paper
• Thrombopoietin upregulates the promoter conformation of p53 in a proliferation-independent manner coincident with a decreased expression of Bax: potential mechanisms for survival enhancing effects.

  1997cited by this paper
• Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.

  1996cited by this paper
• Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

  1996cited by this paper
• Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.

  1995cited by this paper
• Establishment of a myeloid leukaemic cell line (SKNO‐1) from a patient with t(8;21) who acquired monosomy 17 during disease progression

  1995cited by this paper
• Flexibility: the key to p53 function?

  1995cited by this paper
• Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells.

  1994cited by this paper
• Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

  1994cited by this paper
• Conformational change of p53 protein in growth factor-stimulated human myelogenous leukemia cells.

  1994cited by this paper
• Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas.

  1993cited by this paper
• A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53.

  1993cited by this paper
• A comparison of the biological activities of wild‐type and mutant p53

  1993cited by this paper
• p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy.

  1993cited by this paper
• Mutations of p53 and human papillomavirus infection in cervical carcinoma

  1993cited by this paper
• p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy

  1993cited by this paper
• Frequent mutations in the p53 gene in human myeloid leukemia cell lines.

  1992cited by this paper
• p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

  1992cited by this paper
• PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.

  1991cited by this paper
• Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation.

  1991cited by this paper
• Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis.

  1991cited by this paper
• Mast cell growth factor, a ligand for the receptor encoded by c-kit, affects the growth in culture of the blast cells of acute myeloblastic leukemia.

  1991cited by this paper
• Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.

  1991cited by this paper
• A conformation hypothesis for the suppressor and promoter functions of p53 in cell growth control and in cancer

  1991cited by this paper
• NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3).

  1991cited by this paper
• Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.

  1991cited by this paper
• p53: oncogene or anti-oncogene?

  1990cited by this paper
• Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.

  1990cited by this paper
• Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.

  1990cited by this paper
• Structural aspects of the p53 protein in relation to gene evolution.

  1990cited by this paper
• p53: a frequent target for genetic abnormalities in lung cancer.

  1989cited by this paper
• Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

  1989cited by this paper
• Identification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1.

  1989cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Expression of a retinoic acid receptor gene in myeloid leukemia cells.

  1989cited by this paper
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

  1989cited by this paper
• Selective growth response to IL‐3 of a human leukaemic cell line with megakaryoblastic features

  1988cited by this paper
• Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes

  1988cited by this paper
• Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines

  1987cited by this paper
• Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines.

  1987cited by this paper
• Characterization of the human p53 gene

  1986cited by this paper
• Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

  1985cited by this paper
• Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

  1985cited by this paper
• Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome.

  1985cited by this paper
• Establishment of a Ph1-positive human cell line (BV173).

  1983cited by this paper
• Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes

  1982cited by this paper
• Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes.

  1982cited by this paper
• Establishment and characterization of a new permanent cell line (GDM-1) from a patient with myelomonoblastic leukemia.

  1982cited by this paper
• Malignant lymphoma of pre‐T‐cell type terminating in acute myelocytic leukemia. A case report with enzymic and immunologic marker studies

  1980cited by this paper
• Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)

  1980cited by this paper
• Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia

  1979cited by this paper
• Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia.

  1979cited by this paper
• Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity.

  1978cited by this paper

• Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance

  2021cites this paper
• Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System

  2021cites this paper
• A Comparison of p53 Isoform Profiles and Apoptosis Induced by Camptothecin or a Herbal Khat Extract (Catha Edulis (Vahl) Forssk. ex Endl.) in Leukemic Cell Lines: Exploring Cellular Responses in Therapy Development

  2020cites this paper
• Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia.

  2019cites this paper
• Arsenic trioxide and all-trans-retinoic acid selectively exert synergistic cytotoxicity against FLT3-ITD AML cells via co-inhibition of FLT3 signaling pathways

  2017cites this paper
• Cholinergic activation enhances retinoic acid-induced differentiation in the human NB-4 acute promyelocytic leukemia cell line.

  2016cites this paper
• Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo

  2015cites this paper
• Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4

  2014influential citation
• Discovery of Highly Potent p53-MDM2 Antagonists and Structural Basis for Anti-Acute Myeloid Leukemia Activities

  2014cites this paper
• The Novel Chk1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

  2013cites this paper
• Chemical Therapeutics The Novel Chk 1 Inhibitor MK-8776 Sensitizes Human Leukemia Cells to HDAC Inhibitors by Targeting the Intra-S Checkpoint and DNA Replication and Repair

  2013cites this paper
• Restoration of INK4a/ARF gene inhibits cell growth and cooperates with imatinib mesylate in Philadelphia chromosome-positive leukemias.

  2013cites this paper
• Estudo de alterações genéticas associadas à leucemia/linfoma de células T do adulto no estado da Bahia

  2012cites this paper
• MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia

  2010cites this paper
• Delineating cellular and molecular mechanisms of toxicity of an extract of khat ( Catha edulis Forsk . ) in leukemia and normal peripheral blood cells

  2010cites this paper
• Pml and TAp73 interacting at nuclear body mediate imatinib‐induced p53‐independent apoptosis of chronic myeloid leukemia cells

  2009cites this paper
• Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide

  2009cites this paper
• Promyelocytic leukemia protein is required for gain of function by mutant p53.

  2009cites this paper
• Label-free voltammetric detection of single-nucleotide mismatches recognized by the protein MutS

  2007cites this paper
• Regulation of tumor suppressor protein p53 in cellular stress and tumorigenesis

  2007cites this paper
• Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells

  2007influential citation
• Flt3 receptor tyrosine kinase in AML and its modulation of the p53/Hdm2/Bcl-2 pathway

  2007cites this paper
• Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies.

  2006cites this paper
• PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion

  2006influential citation
• SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells

  2005cites this paper
• 5‐Aza‐2′‐deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53‐independent apoptosis in myeloid leukemia

  2005cites this paper
• MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

  2005cites this paper
• Detecting DNA Damage with Electrodes

  2005cites this paper
• Decitabine activates specific caspases downstream of p73 in myeloid leukemia

  2005influential citation
• Induction of Apoptosis in Leukemic Cells by Homovanillic Acid Derivative, Capsaicin, through Oxidative Stress

  2004cites this paper
• Molecular Basis of p53 Functional Inactivation by the Leukemic Protein MLL-ELL

  2003cites this paper
• PPM1D is a potential target for 17q gain in neuroblastoma.

  2003cites this paper